Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,94116,960 of 20,252 grants

Active NON-SBIR/STTR RPGS
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE University of Texas At Austin United States 2021 – 2026

PROJECT SUMMARY The overall goal of the proposed research is to understand the role of Twist1 in cutaneous squamous cell carcinoma (cSCC) and to develop novel approaches for target...

$3.44M
USD
Active NON-SBIR/STTR RPGS
Vascularized tumor explants for drug testing
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

Project Abstract Our understanding of cancer progression or response to therapies would benefit from easily accessible, patient- specific assays that recapitulate the biology and a...

$3.59M
USD
Active NON-SBIR/STTR RPGS
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2026

Title: Enhancing the efficacy of androgen signaling inhibitors in prostate cancer Abstract It has been documented that androgen receptor (AR) signaling remains to play a critical r...

$4.7M
USD
Active OTHER RESEARCH-RELATED
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY Immune checkpoint inhibitors (ICIs) provide durable clinical responses in about 20% of cancer patients, but have minimal effects in cancers lacking intra–tumoral T...

$2.22M
USD
Active NON-SBIR/STTR RPGS
Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Cancer is a common diagnosis in the emergency department (ED) and by the time patients reach the ED, their cancer has often progressed to later stages. EDs...

$4.68M
USD
Active OTHER RESEARCH-RELATED
UCSF Paul Calabresi K12 Career Development Program in Clinical Oncology
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

Project Summary/Abstract The goal of the UCSF Paul Calabresi Career Development Award for Clinical Oncology is to foster the development of the next generation of clinical scientis...

$7.05M
USD
Active NON-SBIR/STTR RPGS
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2026

Project Summary Cancer is a leading cause of death worldwide. Recent advancements in the use of immune checkpoint blockade have transformed oncology, and immunotherapy has extended...

$3.92M
USD
Completed NON-SBIR/STTR RPGS
Dissecting the oncogenic and pro-metastatic roles of PTHLH-mediated calcium signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2021 – 2025

PROJECT SUMMARY Pancreatic cancer is a major health issue in the US, with only 7% of patients surviving beyond 5-years and nearly all patients presenting with metastases. Identifyi...

$2.49M
USD
Completed NON-SBIR/STTR RPGS
Investigating Cellular Communication in the Tumor Microenvironment in Pancreatic Cancer
NATIONAL CANCER INSTITUTE Henry Ford Health System United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDA) is projected to become the 2nd leading cause of cancer-related deaths world-wide by 2030, largely due a lack of effe...

$2.49M
USD
Completed TRAINING, INDIVIDUAL
Function of Musashi-2 Methylation in Normal and Malignant Hematopoiesis
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2024

Project Abstract Acute myeloid leukemia (AML) is an aggressive, heterogeneous disease and is characterized by the expansion of immature myeloid progenitors and the inhibition of my...

$476.9K
USD
Completed TRAINING, INDIVIDUAL
Ovarian Inflammaging as a Mechanism for Ovarian Cancer
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2024

PROJECT SUMMARY High-grade serous ovarian carcinoma (HGSOC) is the most lethal cancer of the female reproductive system with less than 50% of patients surviving 5-years after diagn...

$412.1K
USD
Active OTHER RESEARCH-RELATED
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide. The development of targeted molecular therapies that inhibit m...

$2.09M
USD
Active NON-SBIR/STTR RPGS
Statistical methods for cancer mutational signatures
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary Carcinogens and evolutionary pressures generate unique patterns in the types of somatic mutations observed in the DNA of cancer cells. Mutational signature analysis...

$3.79M
USD
Active OTHER RESEARCH-RELATED
Infection-Associated Cancer Research Training Program in Mali
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

PROJECT SUMMARY The Northwestern University (NU) and Mali’s University of Sciences, Techniques, and Technologies of Bamako (USTTB)’s Infection-Associated Cancer (NM-IAC) Research T...

$2.59M
USD
Completed NON-SBIR/STTR RPGS
Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2025

PROJECT SUMMARY Clinical implementation of Precision Medicine faces major challenges in precision disease stratification and staging, determining optimal treatment, monitoring ther...

$2.57M
USD
Active NON-SBIR/STTR RPGS
Dissecting the Role of Proteostasis in Anti-Androgen Resistant Prostate Cancer
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2026

PROJECT ABSTRACT In the United States, prostate cancer (PCa) is predicted to be the second leading cause of cancer related death in men in the United States in 2020. After initial...

$3.41M
USD
Completed NON-SBIR/STTR RPGS
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
NATIONAL CANCER INSTITUTE Loyola Marymount University United States 2021 – 2025

Project Summary Given advances in screening and treatment, the number of people in the U.S. living with lung cancer is expected to increase by 25% (from 571,340 to 724,610) by 2030...

$207.7K
USD
Active NON-SBIR/STTR RPGS
Adapting and implementing evidence-based breast cancer follow-up in primary care
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Breast cancer survivors are a growing population and their symptom burden is significant. Despite growing evidence on specific symptoms and risk management...

$2.29M
USD
Active NON-SBIR/STTR RPGS
Improving the translational value of head and neck cancer patient-in-mouse models
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

Project Abstract: Patient-derived model systems are commonly used to study tumor biology and test novel treatments for head and neck cancer. These models are established using pati...

$713.5K
USD
Active NON-SBIR/STTR RPGS
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Project Summary Resistance to therapy is the major challenge for the treatment of pancreatic cancer. Despite recent successes in immune checkpoint therapy of several human cancer t...

$692.5K
USD